Researcher
Xavier Sagaert
- Disciplines:Macromolecular and materials chemistry, Laboratory medicine, Morphological sciences
Affiliations
- Translational Cell & Tissue Research (Division)
Member
From1 Oct 2002 → Today
Projects
1 - 7 of 7
- Querying and exploiting the spatial colorectal tumor ecosystem for novel biological, diagnostic and therapeutic insightsFrom1 Oct 2022 → TodayFunding: BOF - projects, Fund Recuperation Fiscal Exemption
- Integration of complementary, high throughput single-cell omics with spatial resolution.From1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- Novel strategies for organ sparing in patients with complete response to radiochemotherapy in locally advanced rectal cancer.From1 Jan 2014 → 31 Dec 2017Funding: Private funding of national origin - undefined
- Clinical impact of protein aggregation in cancer.From1 Oct 2012 → 30 Sep 2017Funding: BOF - Other initiatives
- Response prediction of rectal cancer based on molecular and functional characteristics of the tumor.From1 Dec 2011 → 28 Feb 2015Funding: IWT - TBM (Applied Biomedical Research)
- The role of the forkhead transcription factor FOXP1 in cancer.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
- Unravelling the mechanisms of tumor heterogeneity and budding in colorectal cancer.From1 Oct 2010 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
41 - 50 of 118
- Neoadjuvant chemoradiation treatment followed by surgery for esophageal cancer: there is much more than th mandard tumor regression score(2016)
Authors: Lieven Depypere, Johnny Moons, Toni Lerut, Gert De Hertogh, Xavier Sagaert, Willy Coosemans, Hans Van Veer, Philippe Nafteux
Pages: 149 - 155 - Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics(2016)
Authors: Thomas Tousseyn, Xavier Sagaert
- Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival(2016)
Authors: Geert Maleux, Christophe Deroose, Annouschka Laenen, Chris Verslype, Sam Heye, Karin Haustermans, Gert De Hertogh, Xavier Sagaert, Baki Topal, Hans Prenen, et al.
Pages: 486 - 495 - Oesophageal cancer(2016)
Authors: Peter Dirix, Karin Haustermans, Eric Van Cutsem, Xavier Sagaert, Christophe Deroose, Philippe Nafteux, Hans Prenen, Toni Lerut
Pages: 365 - 387 - Tumour regression in rectal cancer: What is the most robust tumour regression grade system?(2016)
Authors: Linde De Smedt, Sander Palmans, FM Bosisio, F Ballaux, K Wetzels, I Joye, Annelies Debucquoy, André D'Hoore, Karin Haustermans, Xavier Sagaert
Pages: S149 - S149 - Secondary B-cell lymphoma associated with the Epstein-Barr virus in chronic lymphocytic leukemia patients(2016)
Authors: Julie Morscio, Olivier Gheysens, Peter Vandenberghe, Gregor Verhoef, Philippe Demaerel, Daan Dierickx, Xavier Sagaert, Ann Janssens, Thomas Tousseyn
Pages: 113 - 120 - Oesophageal biopsies are insufficient to predict final histology after endoscopic resection in early Barrett's neoplasia(2016)
Authors: Gert De Hertogh, Xavier Sagaert, Georges Coremans, Ingrid Demedts, Raf Bisschops
Pages: 663 - 668 - Tumour budding in colorectal cancer: what do we know and what can we do?(2016)
Authors: Linde De Smedt, Xavier Sagaert
Pages: 397 - 408 - Does Integrating Functional Imaging and Molecular Markers Contribute to a Better Prediction of the Tumoral Response After Preoperative Chemoradiation Therapy for Rectal Cancer?(2016)
Authors: I Joye, Annelies Debucquoy, Christophe Deroose, Vincent Vandecaveye, Eric Van Cutsem, Albert Wolthuis, André D'Hoore, Xavier Sagaert, Olivier Gevaert, Karin Haustermans
Pages: E171 - E171 - Can clinical factors be used as a selection tool for an organ-preserving strategy in rectal cancer?(2016)
Authors: Ines Joye, Annelies Debucquoy, Steffen Fieuws, Albert Wolthuis, Xavier Sagaert, Karin Haustermans
Pages: 1047 - 1052